138 related articles for article (PubMed ID: 21081199)
21. Use of proteomics for the identification of novel drug targets in brain diseases.
Morón JA; Devi LA
J Neurochem; 2007 Jul; 102(2):306-15. PubMed ID: 17419802
[TBL] [Abstract][Full Text] [Related]
22. The application of neuroimaging techniques to drug development.
Tamminga CA; Conley RR
J Clin Psychiatry; 1997; 58 Suppl 10():3-6. PubMed ID: 9265909
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of metaquant microdialysis for measurement of absolute concentrations of amphetamine and dopamine in brain: a viable method for assessing pharmacokinetic profile of drugs in the brain.
Sood P; Cole S; Fraier D; Young AM
J Neurosci Methods; 2009 Dec; 185(1):39-44. PubMed ID: 19747947
[TBL] [Abstract][Full Text] [Related]
24. A regiospecific synthesis of a series of 1-sulfonyl azepinoindoles as potent 5-HT6 ligands.
Liu KG; Lo JR; Comery TA; Zhang GM; Zhang JY; Kowal DM; Smith DL; Di L; Kerns EH; Schechter LE; Robichaud AJ
Bioorg Med Chem Lett; 2008 Jul; 18(14):3929-31. PubMed ID: 18583130
[TBL] [Abstract][Full Text] [Related]
25. 5-Hydroxytryptamine receptors.
Zifa E; Fillion G
Pharmacol Rev; 1992 Sep; 44(3):401-58. PubMed ID: 1359584
[No Abstract] [Full Text] [Related]
26. Strains of rodents and the pharmacology of learning and memory.
Ammassari-Teule M; Castellano C
Neural Plast; 2004; 11(3-4):205-16. PubMed ID: 15656269
[TBL] [Abstract][Full Text] [Related]
27. Binding of isotryptamines and indenes at h5-HT6 serotonin receptors.
Kolanos R; Siripurapu U; Pullagurla M; Riaz M; Setola V; Roth BL; Dukat M; Glennon RA
Bioorg Med Chem Lett; 2005 Apr; 15(8):1987-91. PubMed ID: 15808453
[TBL] [Abstract][Full Text] [Related]
28. Schizophrenia susceptibility genes: in search of a molecular logic and novel drug targets for a devastating disorder.
Gogos JA
Int Rev Neurobiol; 2007; 78():397-422. PubMed ID: 17349868
[TBL] [Abstract][Full Text] [Related]
29. [The serotoninergic mechanism and the experimental therapy of sleep disorders in desynchronization].
Gromov LA; Pishel' VIa
Patol Fiziol Eksp Ter; 1990; (2):22-3. PubMed ID: 2381743
[TBL] [Abstract][Full Text] [Related]
30. Pharmacology. 5-HT3 receptors in the brain?
Bradley P
Nature; 1987 Dec 24-31; 330(6150):696. PubMed ID: 3696232
[No Abstract] [Full Text] [Related]
31. Interaction of chiral MS-245 analogs at h5-HT6 receptors.
Abate C; Kolanos R; Dukat M; Setola V; Roth BL; Glennon RA
Bioorg Med Chem Lett; 2005 Aug; 15(15):3510-3. PubMed ID: 15990303
[TBL] [Abstract][Full Text] [Related]
32. The Journal of Neuroimmune Pharmacology reaches its stride.
Gendelman HE
J Neuroimmune Pharmacol; 2007 Jun; 2(2):129-30. PubMed ID: 18040836
[No Abstract] [Full Text] [Related]
33. In the search for selective ligands of 5-HT5, 5-HT6 and 5-HT7 serotonin receptors.
Wesołowska A
Pol J Pharmacol; 2002; 54(4):327-41. PubMed ID: 12523486
[TBL] [Abstract][Full Text] [Related]
34. The neuropharmacology of L-theanine(N-ethyl-L-glutamine): a possible neuroprotective and cognitive enhancing agent.
Nathan PJ; Lu K; Gray M; Oliver C
J Herb Pharmacother; 2006; 6(2):21-30. PubMed ID: 17182482
[TBL] [Abstract][Full Text] [Related]
35. Cocaine abuse: neurochemistry, phenomenology, and treatment.
Gold MS; Washton AM; Dackis CA
NIDA Res Monogr; 1985; 61():130-50. PubMed ID: 3932873
[No Abstract] [Full Text] [Related]
36. [Alcohol dependence and the serotoninergic system: therapeutic implications].
Arranz B; San L
Med Clin (Barc); 1997 Nov; 109(15):599-605. PubMed ID: 9441197
[No Abstract] [Full Text] [Related]
37. [Serotonin receptors in the brain of animals selected for their domesticated type of behavior].
Maslova GB; Avgustinovich DF
Zh Vyssh Nerv Deiat Im I P Pavlova; 1989; 39(4):627-32. PubMed ID: 2816046
[TBL] [Abstract][Full Text] [Related]
38. Activity of Parthenolide at 5HT2A receptors.
Weber JT; O'Connor MF; Hayataka K; Colson N; Medora R; Russo EB; Parker KK
J Nat Prod; 1997 Jun; 60(6):651-3. PubMed ID: 9214741
[TBL] [Abstract][Full Text] [Related]
39. 5-Cyclic amine-3-arylsulfonylindazoles as novel 5-HT6 receptor antagonists.
Haydar SN; Yun H; Andrae PM; Mattes J; Zhang J; Kramer A; Smith DL; Huselton C; Graf R; Aschmies S; Schechter LE; Comery TA; Robichaud AJ
J Med Chem; 2010 Mar; 53(6):2521-7. PubMed ID: 20170099
[TBL] [Abstract][Full Text] [Related]
40. 2-Alkyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indoles as novel 5-HT6 receptor agonists.
Mattsson C; Sonesson C; Sandahl A; Greiner HE; Gassen M; Plaschke J; Leibrock J; Böttcher H
Bioorg Med Chem Lett; 2005 Oct; 15(19):4230-4. PubMed ID: 16055331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
